Correction to: CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer (Oncogene, (2010), 29, 48, (6390-6401), 10.1038/onc.2010.361);CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer

Oncogene

Volumn 29, Issue 48, 2010, Pages 6390-6401

  Lujambio, A ^a   Portela, A ^a   Liz, J ^a   Melo, S A ^a   Rossi, S ^b   Spizzo, R ^b   Croce, C M ^c   Calin, G A ^b   Esteller, M ^a,d  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b TEXAS STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

CpG island; DNA methylation; epigenetics; non coding RNA

Indexed keywords

UNTRANSLATED RNA;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL TRANSFORMATION; CONTROLLED STUDY; CPG ISLAND; DNA HYBRIDIZATION; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; DNA STRUCTURE; EPIGENETICS; GENE LOCATION; GENE SILENCING; GENETIC ASSOCIATION; GENOME; HUMAN; HUMAN CELL; HUMAN GENOME; MOUSE; NEOPLASM; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; RAT; TRANSCRIBED ULTRACONSERVED REGION;

RATTUS;

EID: 78649881517     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/s41388-018-0560-1     Document Type: Erratum

References (60)

1. Ambros V. (2004). The functions of animal microRNAs. Nature 431: 350-355.
2. Ballestar E, Paz MF, Valle L, Wei S, Fraga MF, Espada J et al. (2003). Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J 22: 6335-6345.
3. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
4. Bejerano G, Lowe CB, Ahituv N, King B, Siepel A, Salama SR et al. (2006). A distal enhancer and an ultraconserved exon are derived from a novel retroposon. Nature 441: 87-90.
5. Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS et al. (2004). Ultraconserved elements in the human genome. Science 304: 1321-1325.
6. Calin GA, Croce CM. (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
7. Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C et al. (2007). Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12: 215-229.
8. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD et al. (2004a). MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101: 11755-11760.
9. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. (2004b). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004.
10. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. (2008). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43-50.
11. Chen LL, Carmichael GG. (2009). Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol Cell 35: 467-478.
12. Davalos V, Esteller M. (2010). MicroRNAs and cancer epigenetics: a macrorevolution. Curr Opin Oncol 22: 35-45.
13. Duursma AM, Kedde M, Schrier M le, Sage C, Agami R (2008). miR-148 targets human DNMT3b protein coding region. RNA, 14, 872-877.
14. Esquela-Kerscher A, Slack FJ. (2006). OncomiRs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
15. Esteller M. (2007). Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298.
16. Esteller M. (2008). Epigenetics in cancer. N Engl J Med 358: 1148-1159.
17. Hammond SM. (2007). MicroRNAs as tumor suppressors. Nat Genet 39: 582-583.
18. Han L, Witmer PD, Casey E, Valle D, Sukumar S. (2007). DNA methylation regulates MicroRNA expression. Cancer Biol Ther 6: 1284-1288.
19. He L, Hannon GJ. (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531.
20. Henikoff S. (2007). Nucleosomes at active promoters: unforgettable loss. Cancer Cell 12: 407-409.
21. Henikoff S. (2008). Nucleosome destabilization in the epigenetic regulation of gene expression. Nat Rev Genet 9: 15-26.
22. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP et al. (1998). Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95: 6870-6875.
23. Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D et al. (2009). DICER1 mutations in familial pleuropulmonary blastoma. Science 325: 965.
24. Huang YW, Liu JC, Deatherage DE, Luo J, Mutch DG, Goodfellow PJ et al. (2009). Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res 69: 9038-9046.
25. International Human Genome Sequencing Consortium (2004). Finishing the euchromatic sequence of the human genome. Nature 431: 931-945.
26. Iwama H, Masaki T, Kuriyama S. (2007). Abundance of microRNA target motifs in the 3'-UTRs of 20527 human genes. FEBS Lett 581: 1805-1810.
27. Jacinto FV, Ballestar E, Esteller M. (2009). Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation. Oncogene 28: 4212-4224.
28. Jones PA, Baylin SB. (2007). The epigenomics of cancer. Cell 128: 683-692.
29. Katzman S, Kern AD, Bejerano G, Fewell G, Fulton L, Wilson RK et al. (2007). Human genome ultraconserved elements are ultra-selected. Science 317: 915.
30. Lareau LF, Inada M, Green RE, Wengrod JC, Brenner SE. (2007). Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446: 926-929.
31. Lin JC, Jeong S, Liang G, Takai D, Fatemi M, Tsai YC et al. (2007). Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell 12: 432-444.
32. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M et al. (2004). An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101: 9740-9744.
33. Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
34. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
35. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D et al. (2008). A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105: 13556-13561.
36. Lujambio A, Esteller M. (2007). CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle 6: 1455-1459.
37. Lujambio A, Esteller M. (2009). How epigenetics can explain human metastasis: a new role for microRNAs. Cell Cycle 8: 377-382.
38. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F et al. (2007). Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67: 1424-1429.
39. Mattick JS. (2003). Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms. BioEssays 25: 930-939.
40. McGarvey KM, Van Neste L, Cope L, Ohm JE, Herman JG, Van Criekinge W et al. (2008). Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells. Cancer Res 68: 5753-5759.
41. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA et al. (2009). A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 41: 365-370.
42. Mendell JT. (2005). MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 4: 1179-1184.
43. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R et al. (2008). Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359: 2641-2650.
44. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM et al. (2006). A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217.
45. Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G et al. (2002). Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine. Cancer Res 62: 6456-6461.
46. Nobrega MA, Ovcharenko I, Afzal V, Rubin EM. (2003). Scanning human gene deserts for long-range enhancers. Science 302: 413.
47. Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, Shoukry M et al. (2006). In vivo enhancer analysis of human conserved non-coding sequences. Nature 444: 499-502.
48. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE et al. (2002). DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416: 552-556.
49. Rossi S, Sevignani C, Nnadi SC, Siracusa LD, Calin GA. (2008). Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinfor-matics and therapeutic implications. Mamm Genome 19: 526-540.
50. Saini HK, Griffiths-Jones S, Enright AJ. (2007). Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci USA 104: 17719-17724.
51. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA et al. (2006). Specific activation of microRNA-127 with down-regulation of the protooncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435-443.
52. Schuebel KE, Chen W, Cope L, Glockner SC, Suzuki H, Yi JM et al. (2007). Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 3: 1709-1723.
53. Spizzo R, Nicoloso MS, Croce CM, Calin GA. (2009). SnapShot: microRNAs in cancer. Cell 137: 586-586.
54. Takai D, Jones PA. (2003). The CpG island searcher: a new WWW resource. In Silico Biol 3: 235-240.
55. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM. (2006). Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20: 2202-2207.
56. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y et al. (2008). Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68: 4123-4132.
57. Velculescu VE. (2008). Defining the blueprint of the cancer genome. Carcinogenesis 29: 1087-1091.
58. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
59. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A et al. (2006). microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103: 9136-9141.
60. Zhou X, Ruan J, Wang G, Zhang W. (2007). Characterization and identification of microRNA core promoters in four model species. Plos Comput Biol 3: e37.